title: Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats.
abstract: A quantitative autoradiographic study was performed to determine whether kinin receptors are altered in the rat spinal cord in an experimental model of arterial hypertension under antioxidant therapy with alpha-lipoic acid. Sprague-Dawley rats were fed for 4 weeks with a normal chow diet or with an alpha-lipoic acid supplemented diet (1000 mg/kg feed), and treated for the last 2 weeks with angiotensin II (AT II) (200 ng/kg/min with an osmotic pump implanted s.c.). Control rats received either diet but not AT II. A 2-week administration of AT II increased significantly systolic blood pressure, the production of superoxide anion in the aorta and B1 receptor binding sites in the thoracic spinal dorsal horn. This treatment did not affect spinal B2 receptor binding sites, glycemia and insulinemia. The diet supplemented with alpha-lipoic acid reduced significantly the increase in systolic blood pressure, the production of aortic superoxide anion and prevented the increases of B1 receptor binding sites. Results show an association between the oxidative stress and the increases of B1 receptors and arterial blood pressure induced by AT II. Data also exclude the possibility that arterial hypertension is a primary mechanism leading to an increase of B2 receptor binding sites in the rat spinal cord.
authors.affiliation: Department of Physiology, Faculty of Medicine, Université de Montréal, C.P. 6128, Succursale Centre-ville, Montréal, Que., Canada H3C 3J7.
authors.forename: Mihai
authors.initials: M
authors.lastname: Petcu
authors.forename: Brice
authors.initials: B
authors.lastname: Ongali
authors.forename: Adil
authors.initials: A
authors.lastname: El Midaoui
authors.forename: Jacques
authors.initials: J
authors.lastname: de Champlain
authors.forename: Réjean
authors.initials: R
authors.lastname: Couture
mesh_terms: D000804:Angiotensin II / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002908:Chronic Disease; D004032:Diet; D004195:Disease Models, Animal; D007328:Insulin / Q000378:metabolism; D051381:Rats; D043783:Receptor, Bradykinin B1 / Q000187:drug effects* / Q000378:metabolism; D043782:Receptor, Bradykinin B2 / Q000187:drug effects* / Q000378:metabolism; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*; D013481:Superoxides / Q000378:metabolism; D008063:Thioctic Acid / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D013481:Superoxides; D000804:Angiotensin II; D008063:Thioctic Acid